financetom
Business
financetom
/
Business
/
Align Technology misses third-quarter revenue estimates on weaker demand for teeth aligners
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Align Technology misses third-quarter revenue estimates on weaker demand for teeth aligners
Oct 30, 2024 7:10 PM

Oct 23 (Reuters) - Align Technology ( ALGN ) missed Wall

Street estimates for third-quarter revenue on Wednesday, on

lower-than-expected demand for its clear teeth aligners among

younger patients.

Shares of the company were down about 3.9% after the bell.

The Arizona-based company posted third-quarter revenue of

$977.9 million, down 4.9% sequentially, missing estimates of

$987.34 million, according to data complied by LSEG.

The company also announced a global restructuring plan which

would lead to job cuts or transfers for certain identified

positions to other locations.

Align expects to spend about $30 million on severance

payments in the fourth-quarter.

The company had said in July that it expects clear teeth

aligner volume to be down sequentially as a result of

third-quarter seasonality. Volumes were down 4% during the

quarter.

Leerink Partners analyst Michael Cherny, earlier this month,

had said in a note that sentiment towards the dental industry

remains largely poor, heading into the third quarter, "driven by

both industry pressures and company-specific variables that are

limiting any meaningful enthusiasm".

"As recently reported by many analysts and third-party

research firms, the underlying dental market in the U.S. remains

sluggish and our doctor customers cite similar trends," Align

CEO Joe Hogan said in a statement.

In July, the company reduced its annual growth forecast due

to weak demand. The demand for dental products and surgeries has

decreased, as consumers concerned about inflation choose to

limit their discretionary spending and prioritize purchase of

essential products.

The Invisalign maker expects fourth-quarter global revenue

to be in the range of $995 million to $1.02 billion, compared to

analysts' estimates of $1.01 billion.

On an adjusted basis, the company posted a profit of $2.35

per share, compared to estimates of $2.31 per share, according

to data compiled by LSEG.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
KKR and state-backed JIC join forces to take Japan's Topcon private for $2.31 billion
KKR and state-backed JIC join forces to take Japan's Topcon private for $2.31 billion
Mar 28, 2025
TOKYO, March 28 (Reuters) - U.S.-based private equity firm KKR and Japanese state-backed fund Japan Investment Corp (JIC) will acquire medical gear maker Topcon ( TOPCF ) in a tender offer buyout worth 348 billion yen ($2.3 billion), KKR said on Friday. Private equity deals in Japan have been booming as corporate governance reforms and increasingly vocal activist shareholders push...
Rio Tinto in talks with Congo to develop lithium deposit, Bloomberg News reports
Rio Tinto in talks with Congo to develop lithium deposit, Bloomberg News reports
Mar 28, 2025
(Reuters) -Rio Tinto has held talks with the Democratic Republic of Congo about developing one of the world's biggest hard rock lithium deposits, Bloomberg News reported on Friday, citing people familiar with the matter. The discussions, which are in the preliminary stages, focus on Rio Tinto getting involved in transforming the Roche Dure resource into a lithium mine, the report...
Google to pay $100 million to settle advertisers' class action
Google to pay $100 million to settle advertisers' class action
Mar 28, 2025
March 28 (Reuters) - Google has agreed to pay $100 million in cash to settle a long-running lawsuit claiming it overcharged advertisers by failing to provide promised discounts and charged for clicks on ads outside the geographic areas the advertisers targeted. A preliminary settlement of the 14-year-old class action, which began in March 2011, was filed late Thursday in the...
Verona Pharma Re-Works Loan Packages, Boosting Borrowing Capacity, Lowering Expense
Verona Pharma Re-Works Loan Packages, Boosting Borrowing Capacity, Lowering Expense
Mar 28, 2025
09:28 AM EDT, 03/28/2025 (MT Newswires) -- Verona Pharma ( VRNA ) said Friday that it has revised its existing funding agreements by repaying its $100 million revenue interest purchase and sale agreement and increasing its debt facility with funds managed by Oaktree Capital Management and Omers Life Sciences to $450 million on improved terms. The biopharmaceutical company said it...
Copyright 2023-2026 - www.financetom.com All Rights Reserved